The future of Diabetic Kidney Disease management: reducing the unmet need

ανά de Zeeuw, Dick
Τόπος έκδοσης J Nephrol (2020)

The Kidney in Type 2 Diabetes Therapy

ανά Lambers Heerspink, Hiddo J., de Zeeuw, Dick
Έκδοση 2011

Novel drugs and intervention strategies for the treatment of chronic kidney disease

ανά Lambers Heerspink, Hiddo Jan, de Zeeuw, Dick
Έκδοση 2013

Are Post-Trial Observational Studies Useful?

ανά Heerspink, Hiddo J. Lambers, de Zeeuw, Dick
Έκδοση 2014

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

ανά Heerspink, Hiddo J. L., De Zeeuw, Dick
Τόπος έκδοσης Diabetologia (2016)

Treating diabetic complications; from large randomized clinical trials to precision medicine

ανά Heerspink, Hiddo J. L., de Zeeuw, Dick
Τόπος έκδοσης Diabetes Obes Metab (2018)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy

ανά de Zeeuw, Dick, Heerspink, Hiddo J L
Τόπος έκδοσης Nephrol Dial Transplant (2020)

The Geographical Distribution of Leadership in Globalized Clinical Trials

ανά Hoekman, Jarno, Frenken, Koen, de Zeeuw, Dick, Heerspink, Hiddo Lambers
Έκδοση 2012

Intracellular Angiotensin II and cell growth of vascular smooth muscle cells

ανά Filipeanu, Catalin M, Henning, Robert H, de Zeeuw, Dick, Nelemans, Adriaan
Έκδοση 2001

Effects of Dietary Sodium and Hydrochlorothiazide on the Antiproteinuric Efficacy of Losartan

ανά Vogt, Liffert, Waanders, Femke, Boomsma, Frans, de Zeeuw, Dick, Navis, Gerjan
Έκδοση 2008

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709

ανά Lambers Heerspink, Hiddo J., Kwakernaak, Arjan, de Zeeuw, Dick, Navis, Gerjan
Έκδοση 2011

A Longitudinal Study Examining Adherence to Guidelines in Diabetes Care According to Different Definitions of Adequacy and Timeliness

ανά Sidorenkov, Grigory, Haaijer-Ruskamp, Flora M., de Zeeuw, Dick, Denig, Petra
Έκδοση 2011

Monitoring Kidney Function and Albuminuria in Patients With Diabetes

ανά Lambers Heerspink, Hiddo J., Holtkamp, Frank A., de Zeeuw, Dick, Ravid, Mordchai
Έκδοση 2011

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders

ανά Schievink, Bauke, Lambers Heerspink, Hiddo, Leufkens, Hubert, De Zeeuw, Dick, Hoekman, Jarno
Έκδοση 2014

Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study

ανά de Vries, Sieta T, Haaijer-Ruskamp, Flora M, de Zeeuw, Dick, Denig, Petra
Τόπος έκδοσης Health Qual Life Outcomes (2014)

Drug-Induced Reduction in Albuminuria Is Associated with Subsequent Renoprotection: A Meta-Analysis

ανά Lambers Heerspink, Hiddo J., Kröpelin, Tobias F., Hoekman, Jarno, de Zeeuw, Dick
Τόπος έκδοσης J Am Soc Nephrol (2015)

A review of methods used in assessing non-serious adverse drug events in observational studies among type 2 diabetes mellitus patients

ανά Hakobyan, Liana, Haaijer-Ruskamp, Flora M, de Zeeuw, Dick, Dobre, Daniela, Denig, Petra
Έκδοση 2011

Do Treatment Quality Indicators Predict Cardiovascular Outcomes in Patients with Diabetes?

ανά Sidorenkov, Grigory, Voorham, Jaco, de Zeeuw, Dick, Haaijer-Ruskamp, Flora M., Denig, Petra
Έκδοση 2013

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study

ανά Coyne, Daniel W., Andress, Dennis L., Amdahl, Michael J., Ritz, Eberhard, de Zeeuw, Dick
Έκδοση 2013

The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers

ανά Schievink, Bauke, de Zeeuw, Dick, Parving, Hans-Henrik, Rossing, Peter, Lambers Heerspink, Hiddo Jan
Τόπος έκδοσης Br J Clin Pharmacol (2015)